R&G PharmaStudies Co., Ltd. (SHE:301333)

China · Delayed Price · Currency is CNY

78.07

-0.28 (-0.36%)

At close: Feb 12, 2026

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Clinical Trial Operation	319.97M
Clinical Trial Operation Growth	-9.74%
Clinical Trial Site Management	204.73M
Clinical Trial Site Management Growth	10.19%
Data Management and Statistical Analysis	100.68M
Data Management and Statistical Analysis Growth	26.35%
Biological Sample Testing	63.51M
Biological Sample Testing Growth	74.09%
Clinical Pharmacology	32.21M
Clinical Pharmacology Growth	-10.74%
Clinical Trial Consulting	22.91M
Clinical Trial Consulting Growth	-20.56%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	664.58M
China Growth	-1.45%
Overseas	79.42M
Overseas Growth	69.04%